Newsletter 103 – Candidate vaccine for tuberculosis prevention shows promising signs
The safety and efficacy of the vaccine have been assessed in south-saharan Africa on 3,500 adults already infected with the causative agent of tuberculosis. Half of them received the vaccine and the others received placebo
15/02/2020The safety and efficacy of the vaccine have been assessed in south-saharan Africa on 3,500 adults already infected with the causative agent of tuberculosis. Half of them received the vaccine and the others received placebo…
